Belzutifan, PALBOCICLIB clinical trials

A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma

This study is testing new treatments for advanced kidney cancer. Researchers want to see if combining two drugs, Belzutifan and Palbociclib, works better than Belzutifan alone. The goal is to find safer and more effective ways to treat this type of cancer.